Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Dose Finding Study of ZW49 in Patients With HER2-Positive Cancers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03821233
Recruitment Status : Recruiting
First Posted : January 29, 2019
Last Update Posted : April 27, 2022
Information provided by (Responsible Party):
Zymeworks Inc.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : August 2023
Estimated Study Completion Date : August 2025